| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.12B | 103.07B | 95.86B | 90.42B | 84.43B | 80.54B |
| Gross Profit | 20.51B | 19.14B | 17.70B | 15.67B | 14.69B | 14.63B |
| EBITDA | 4.47B | 4.04B | 3.78B | 3.15B | 3.34B | 4.62B |
| Net Income | 2.74B | 2.44B | 2.07B | 960.00M | 1.43B | 2.26B |
Balance Sheet | ||||||
| Total Assets | 96.36B | 94.45B | 95.52B | 86.81B | 86.46B | 82.94B |
| Cash, Cash Equivalents and Short-Term Investments | 8.45B | 8.45B | 8.87B | 7.53B | 6.92B | 6.68B |
| Total Debt | 15.83B | 17.77B | 18.96B | 21.38B | 21.73B | 16.92B |
| Total Liabilities | 46.22B | 46.87B | 48.36B | 45.19B | 46.17B | 41.79B |
| Stockholders Equity | 49.95B | 47.38B | 47.01B | 41.49B | 40.16B | 38.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.36B | 4.63B | 2.41B | -330.00M | 879.00M |
| Operating Cash Flow | 0.00 | 4.24B | 5.60B | 3.66B | 1.09B | 3.61B |
| Investing Cash Flow | 0.00 | -1.48B | -869.00M | -1.45B | -2.09B | -4.63B |
| Financing Cash Flow | 0.00 | -3.20B | -3.81B | -1.54B | 993.00M | 1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥48.70B | 7.95 | ― | 1.90% | 12.47% | 21.98% | |
78 Outperform | ¥344.98B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
73 Outperform | ¥111.36B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
73 Outperform | ¥395.68B | 9.25 | ― | 3.13% | 1.50% | 9.82% | |
69 Neutral | ¥468.86B | 14.68 | ― | 3.37% | 4.50% | -9.36% | |
68 Neutral | ¥109.35B | 9.91 | ― | 2.91% | 31.48% | 83.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |